Related Experiment Video
Updated: Jun 1, 2026
06:13
Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
Exercise training increases adipose tissue GLUT4 expression in patients with type 2 diabetes
Diabetes, Obesity & Metabolism
|May 28, 2011
Summary
Exercise training boosts glucose transporter type 4 (GLUT4) expression in adipose tissue and skeletal muscle for type 2 diabetes (T2D) patients. This adaptation improves glucose uptake, but optimal benefits depend on pancreatic beta-cell function.
Area of Science:
- Endocrinology
- Metabolic Research
- Exercise Physiology
Background:
- Type 2 diabetes (T2D) is characterized by impaired glucose metabolism.
- Reduced glucose transporter type 4 (GLUT4) expression in adipose tissue is observed in T2D.
- The impact of exercise on GLUT4 expression in T2D requires further elucidation.
Discussion:
- Exercise training significantly increased adipose tissue GLUT4 protein expression by 36% in T2D patients.
- Skeletal muscle GLUT4 protein expression also rose by 20% following exercise intervention.
- These findings highlight exercise as a potential therapeutic strategy for improving glucose homeostasis in T2D.
Key Insights:
- Exercise intervention effectively upregulates GLUT4 expression in both adipose and skeletal muscle tissues in individuals with type 2 diabetes.
- Adipose tissue GLUT4 expression was significantly lower in T2D patients compared to controls before training.
- Skeletal muscle GLUT4 expression did not differ between groups initially but increased with exercise.
Outlook:
- Further research is needed to explore the functional consequences of increased GLUT4 expression on insulin sensitivity.
- Investigating the role of beta-cell function in mediating the benefits of exercise-induced GLUT4 changes is crucial.
- Long-term studies are warranted to assess the sustained impact of exercise on glucose control in T2D.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...